1. Faldaprevir combined with peginterferon alfa‐2a and ribavirin in chronic hepatitis C virus genotype‐1 patients with prior nonresponse: SILEN‐C2 trial12. Issue 6 (12th June 2013) Authors: Sulkowski, Mark S.; Bourlière, Marc; Bronowicki, Jean‐Pierre; Asselah, Tarik; Pawlotsky, Jean‐Michel; Shafran, Stephen D.; Pol, Stanislas; Mauss, Stefan; Larrey, Dominique; Datsenko, Yakov; Stern, Jerry O.; Kukolj, George; Scherer, Joseph; Nehmiz, Gerhard; Steinmann, Gerhard G.; Böcher, Wulf O. Journal: Hepatology Issue: Volume 57:Issue 6(2013:Jun.) Page Start: 2155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial12. Issue 6 (12th June 2013) Authors: Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob; Ferenci, Peter; Fainboim, Hugo; Leggett, Barbara; Bessone, Fernando; Mauss, Stefan; Heo, Jeong; Datsenko, Yakov; Stern, Jerry O.; Kukolj, George; Scherer, Joseph; Nehmiz, Gerhard; Steinmann, Gerhard G.; Böcher, Wulf O. Journal: Hepatology Issue: Volume 57:Issue 6(2013:Jun.) Page Start: 2143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Issue 9 (26th June 2018) Authors: Baeten, Dominique; Østergaard, Mikkel; Wei, James Cheng-Chung; Sieper, Joachim; Järvinen, Pentti; Tam, Lai-Shan; Salvarani, Carlo; Kim, Tae-Hwan; Solinger, Alan; Datsenko, Yakov; Pamulapati, Chandrasena; Visvanathan, Sudha; Hall, David B; Aslanyan, Stella; Scholl, Paul; Padula, Steven J Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 9(2018) Page Start: 1295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗